231 related articles for article (PubMed ID: 34471805)
1. Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Major Malformations: The Importance of Serotonin for Embryonic Development and the Effect of Serotonin Inhibition on the Occurrence of Malformations.
Bérard A; Levin M; Sadler T; Healy D
Bioelectricity; 2019 Mar; 1(1):18-29. PubMed ID: 34471805
[TBL] [Abstract][Full Text] [Related]
2. Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis.
Kornum JB; Nielsen RB; Pedersen L; Mortensen PB; Nørgaard M
Clin Epidemiol; 2010 Aug; 2():29-36. PubMed ID: 20865100
[TBL] [Abstract][Full Text] [Related]
3. Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study.
Jimenez-Solem E; Andersen JT; Petersen M; Broedbaek K; Jensen JK; Afzal S; Gislason GH; Torp-Pedersen C; Poulsen HE
BMJ Open; 2012; 2(3):. PubMed ID: 22710132
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy Complications and Neonatal Mortality in a Serotonin Transporter Null Mouse Model: Insight Into the Use of Selective Serotonin Reuptake Inhibitor During Pregnancy.
Domingues RR; Wiltbank MC; Hernandez LL
Front Med (Lausanne); 2022; 9():848581. PubMed ID: 35360732
[TBL] [Abstract][Full Text] [Related]
5. The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring.
Olivier JD; Akerud H; Kaihola H; Pawluski JL; Skalkidou A; Högberg U; Sundström-Poromaa I
Front Cell Neurosci; 2013; 7():73. PubMed ID: 23734100
[TBL] [Abstract][Full Text] [Related]
6. Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy : Effects on the Infant.
Nordeng H; Spigset O
Drug Saf; 2005 Jul; 28(7):565-581. PubMed ID: 27722970
[TBL] [Abstract][Full Text] [Related]
7. Acute selective serotonin reuptake inhibitors regulate the dorsal raphe nucleus causing amplification of terminal serotonin release.
Dankoski EC; Carroll S; Wightman RM
J Neurochem; 2016 Mar; 136(6):1131-1141. PubMed ID: 26749030
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?
Diav-Citrin O; Ornoy A
Obstet Gynecol Int; 2012; 2012():698947. PubMed ID: 22190957
[TBL] [Abstract][Full Text] [Related]
9. Post-SSRI Sexual Dysfunction: A Bioelectric Mechanism?
Healy D; LaPalme J; Levin M
Bioelectricity; 2020 Mar; 2(1):7-13. PubMed ID: 34471832
[TBL] [Abstract][Full Text] [Related]
10. Selective Serotonin Reuptake Inhibitors during Pregnancy: Do We Have Now More Definite Answers Related to Prenatal Exposure?
Ornoy A; Koren G
Birth Defects Res; 2017 Jul; 109(12):898-908. PubMed ID: 28714608
[TBL] [Abstract][Full Text] [Related]
11. Placental serotonin signaling, pregnancy outcomes, and regulation of fetal brain development†.
Rosenfeld CS
Biol Reprod; 2020 Mar; 102(3):532-538. PubMed ID: 31711155
[TBL] [Abstract][Full Text] [Related]
12. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
[TBL] [Abstract][Full Text] [Related]
13. In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat.
Laurent L; Huang C; Ernest SR; Berard A; Vaillancourt C; Hales BF
Birth Defects Res A Clin Mol Teratol; 2016 Dec; 106(12):1044-1055. PubMed ID: 27384265
[TBL] [Abstract][Full Text] [Related]
14. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
15. Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression.
James GM; Baldinger-Melich P; Philippe C; Kranz GS; Vanicek T; Hahn A; Gryglewski G; Hienert M; Spies M; Traub-Weidinger T; Mitterhauser M; Wadsak W; Hacker M; Kasper S; Lanzenberger R
Front Hum Neurosci; 2017; 11():48. PubMed ID: 28220069
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake.
Blom T; Meinsma R; Rutgers M; Buitenhuis C; Dekken-Van den Burg M; van Kuilenburg ABP; Tytgat GAM
EJNMMI Res; 2020 Jul; 10(1):78. PubMed ID: 32642907
[TBL] [Abstract][Full Text] [Related]
17. Loss of Serotonin Transporter Function Alters ADP-mediated Glycoprotein αIIbβ3 Activation through Dysregulation of the 5-HT2A Receptor.
Oliver KH; Duvernay MT; Hamm HE; Carneiro AM
J Biol Chem; 2016 Sep; 291(38):20210-9. PubMed ID: 27422820
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of prenatal antidepressant exposure.
Simon GE; Cunningham ML; Davis RL
Am J Psychiatry; 2002 Dec; 159(12):2055-61. PubMed ID: 12450956
[TBL] [Abstract][Full Text] [Related]
19. Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study.
Reis M; Källén B
BMJ Open; 2013; 3(2):. PubMed ID: 23427202
[TBL] [Abstract][Full Text] [Related]
20. Selective Serotonin Reuptake Inhibitor Use during Pregnancy and the Risk of Autism Spectrum Disorders: A Review.
Boukhris T; Bérard A
J Pediatr Genet; 2015 Jun; 4(2):84-93. PubMed ID: 27617119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
